| Date Filed | Type | Description |
| 01/13/2006 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/21/2005 |
SC 13D
| BVF PARTNERS L P reports a 12.1% stake in Flamel Technologies, S.A. |
| 08/05/2004 |
SC 13D/A
| BVF PARTNERS L P reports a 0% stake in Arena Pharmaceuticals, Inc. |
| 07/12/2004 |
SC 13D/A
| BVF PARTNERS L P reports a 7.5% stake in Arena Pharmaceuticals, Inc. |
| 07/02/2004 |
SC 13D/A
| BVF PARTNERS L P reports a 10.9% stake in Arena Pharmaceuticals, Inc. |
| 01/23/2004 |
SC 13D
| BVF PARTNERS L P reports a 12.2% stake in Arena Pharmaceuticals, Inc. |
| 01/02/2004 |
SC 13D/A
| BVF PARTNERS L P reports a 13.3% stake in Arena Pharmaceuticals, Inc. |
| 12/16/2003 |
SC 13D/A
| BVF PARTNERS L P reports a 18.2% stake in Arena Pharmaceuticals, Inc. |
| 10/22/2003 |
SC 13D/A
| BVF PARTNERS L P reports a 18.2% stake in Arena Pharmaceuticals, Inc. |
| 10/20/2003 |
SC 13D/A
| BVF PARTNERS L P reports a 26.8% stake in Arena Pharmaceuticals, Inc. |
| 10/09/2003 |
SC 13D/A
| BVF PARTNERS L P reports a 26.8% stake in Arena Pharmaceuticals, Inc. |
| 08/21/2003 |
SC 13G
| BVF PARTNERS L P reports a 5.2% stake in Atherogenics, Inc. |
| 06/23/2003 |
SC 13G/A
| BVF PARTNERS L P reports a 0.4% stake in DOV Pharmaceutical, Inc. |
| 05/29/2003 |
SC 13G/A
| BVF PARTNERS L P reports a 10.8% stake in Neurogen Corporation |
| 05/28/2003 |
SC 13G/A
| BVF PARTNERS L P reports a 7.8% stake in Repligen Corporation |
| 05/19/2003 |
SC 13G/A
| BVF PARTNERS L P reports a 7% stake in DOV Pharmaceutical, Inc. |
| 04/16/2003 |
SC 13G/A
| BVF PARTNERS L P reports a 11.3% stake in Array BioPharma, Inc. |
| 04/10/2003 |
SC 13G
| BVF PARTNERS L P reports a 9.8% stake in Array BioPharma, Inc. |
| 04/09/2003 |
SC 13G
| BVF PARTNERS L P reports a 12.2% stake in Flamel Technologies, S.A. |
| 04/04/2003 |
SC 13G
| BVF PARTNERS L P reports a 6.2% stake in Palatin Technologies, Inc. |